INDIA LIVE DESKNIFTY 50:23,140.50(+0.34%)SENSEX:73,895.74(+0.43%)
RDU Global
🇮🇳
Home/Topics/Companies & Institutions/Moderna
Back to Newsroom
🏢Organization Dossier

Moderna

Curated news coverage, institutional background, regulatory filings, and investigative reporting across RDU Global.

7 Stories Indexed
Last Updated: Just Now
Verified Entity Intelligence
Global Health & Biotech 26 Oct 2026, 08:00 PM IST

Landmark Melanoma Vaccine Trial Cuts Recurrence or Death Risk by 42%, Raising Stakes for Cancer Biotech

A first-of-its-kind personalized cancer vaccine has reduced the risk of melanoma recurrence or death by 42% in a landmark trial, according to reports from the European Society for Medical Oncology meeting. The result strengthens the case for individualized immunotherapy and could reshape investor expectations for Moderna, Merck, and the broader oncology biotech sector.

By RDU Global Wire4 min read
Clean Energy & Climate Transition04 Oct 2026, 12:11 PM IST

British Rover Tests in Spain Signal New Push in Mars Search for Ancient Life

A British-built rover prototype nicknamed Charlie is being tested in Spain’s Almería desert as scientists prepare for a possible Mars mission aimed at detecting signs of ancient life. The project underscores how planetary exploration is increasingly tied to advanced robotics, climate-relevant field testing and the search for evidence that could reshape understanding of life beyond Earth.

5 min readRead →
World Politics & Diplomacy04 Oct 2026, 03:26 AM IST

Lula’s Lead Over Bolsonaro Narrows as Brazil Heads Into High-Stakes Vote

A new CNT/MDA poll shows Luiz Inácio Lula da Silva’s advantage over President Jair Bolsonaro tightening ahead of Brazil’s presidential election, underscoring a race that remains volatile in the final stretch. The narrowing margin heightens uncertainty for markets, diplomats and voters as the contest becomes a referendum on Bolsonaro’s record, Lula’s comeback bid and Brazil’s political direction.

5 min readRead →
Global Economy & Central Banks03 Oct 2026, 06:24 PM IST

Ford Holds Off Hyundai to Keep No. 3 U.S. Sales Spot in Third Quarter Despite 6.6% Decline

Ford Motor Co. preserved its No. 3 position in U.S. light-duty vehicle sales in the third quarter, edging out Hyundai even as its sales fell 6.6% year over year to 507,395 units. The result underscores how a softer market and shifting consumer demand are reshaping the competitive order among major automakers, with volume leadership now hinging on execution as much as product mix.

6 min readRead →
Global Health & Biotech11 Oct 2026, 10:14 AM IST

Moderna Shares Jump as Investors Reprice Vaccine and Pipeline Prospects

Moderna stock surged in early trading after investors reassessed the company’s near-term revenue outlook and the market’s appetite for biotech risk. The move reflects a broader shift in sentiment toward companies with visible catalysts, even as Moderna continues to face pressure from declining COVID vaccine demand and a still-developing pipeline.

5 min readRead →
Global Health & Biotech11 Oct 2026, 12:41 AM IST

Moderna Shares Hit Four-Year High as Cancer Vaccine Ambitions Reignite Investor Optimism

Moderna shares surged to a four-year high after reports and market reaction to the company’s planned role in a national cancer vaccine effort revived confidence in its pipeline beyond COVID-19. The move underscores how quickly investors are re-rating the biotech name on the prospect of a larger oncology opportunity, even as the broader cancer vaccine field remains scientifically complex and commercially uncertain.

5 min readRead →
Global Health & Biotech10 Oct 2026, 04:30 PM IST

Moderna Shares Surge as U.S. Cancer Vaccine Push Lifts Biotech Sentiment

Moderna shares jumped sharply after reports that the United States is preparing a national cancer vaccine initiative, fueling investor bets that mRNA technology could gain a major new policy tailwind. The move pushed the stock to a four-year high and reignited debate over whether government backing could accelerate the commercial path for cancer immunotherapy platforms.

4 min readRead →

🏢 About this Entity

Corporations, startups, regulatory bodies, central banks, ministries and judicial courts. All news mentioning this entity is automatically verified and aggregated into this live intelligence dossier.